Search
Incannex Healthcare Inc
IXHLAdd to Watchlist
3.280USD
+0.120+3.80%
Close 08-14 16:00（ET）Quotes delayed by 15 min
44.88MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Incannex Healthcare Inc is 8.00, ranking 59 out of 156 in the Pharmaceuticals industry.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
18.000
Target Price
+469.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Incannex Healthcare Inc
IXHL
1
Beigene Ltd
ONC
28
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
Ionis Pharmaceuticals Inc
IONS
25
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have Incannex Healthcare IncIXHL's recent earnings per share performed?
The market expectation was USD -0.31, while Incannex Healthcare IncIXHL's earnings per share (EPS) for the previous quarter was USD -0.56. EPS for the next quarter is expected at USD -0.53.
What is the analyst rating for Incannex Healthcare Inc?
Based on the ratings of Incannex Healthcare Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.